Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $256,490 were sold by Okupe Oluyemi on Jun 25 ’24. At $22.21 per share, Okupe Oluyemi sold 11,546 shares. The insider’s holdings dropped to 177,449 shares worth approximately $3.55 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Boughton Soleil sold 2,335 shares, netting a total of over 51,790 in proceeds. Following the sale of shares at $22.18 each, the insider now holds 171,479 shares.
Before that, Chi Michael had sold 17,303 shares from its account. In a trade valued at $381,877, the Chief Commercial Officer traded Hims & Hers Health Inc shares for $22.07 each. Upon closing the transaction, the insider’s holdings decreased to 17,303 shares, worth approximately $3.71 million.
As published in a research note from Citigroup on May 22, 2024, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to a Neutral and the price target has been revised to $20 from $16. Analysts at Jefferies downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid April. As of April 10, 2024, Canaccord Genuity has initiated its “Buy” rating for HIMS. Earlier on February 28, 2024, Imperial Capital upgraded its rating. Their new recommendation was “an Outperform” for HIMS stock which previously was a “an In-line”.
Analyzing HIMS Stock Performance
During the last five days, there has been a drop of approximately -10.59%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 124.94%. Shares of the company reached a 52-week high of $25.74 on 06/18/24 and a 52-week low of $8.09 on 01/05/24. A 50-day SMA is recorded $17.09, while a 200-day SMA reached $11.35. Nevertheless, trading volume fell to 25.16 million shares from 11.27 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 18.99, which, if violated, would cause prices to drop to 17.95. In the upper region, resistance lies at 20.87. The next price resistance is at 21.71. RSI (Relative Strength Index) is 47.56 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.04, which suggests the price will decrease in the coming days. Percent R is at 82.42%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
